Precautions for Ad26.ZEBOV / MVA-BN-Filo are Immunocompromise Acute severe febrile illness or acute infection The safety and immunogenicity of the Ad26.ZEBOV / MVA-BN-Filo vaccine regimen have not been assessed in immunocompromised people, including those receiving immunosuppressive therapy.